NCT05921162View on ClinicalTrials.gov

A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection

Enrolling by invitationOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Retinitis PigmentosaRetinal DiseaseRetinal Degeneration
Interventions
BIOLOGICAL

Gene Therapy product:vMCO-I

Safety evaluation to monitor long term effects of previously injected vMCO-I in RP patients

Trial Locations (1)

753014

JPM Rotary Club of Cuttack Eye Hospital and Research Institute, Cuttack

Sponsors
All Listed Sponsors
lead

Nanoscope Therapeutics Inc.

INDUSTRY